Consistent with this laboratory based findings; annexin A1 mRNA levels were significantly higher in basal-like breast cancer patients (n = 139) than in samples from patients with luminal (n = 685) or Her2/neu+ positive (n = 66) cancers (TCGA breast cancer dataset) (Fig 2E). This evidence concerns the gene ERBB2 and breast cancer.